secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001104659-25-036366
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma finalizes interim CEO Iain Dukes' employment; Jack Stover named Chairman
--------------------------------------------------------------------------------

- Employment agreement with Iain Dukes effective April 1, 2025: base salary $610K, target bonus 50% of base.
- Term of one year, auto-renew; severance only after first anniversary unless change in control.
- Dr. Dukes stepped down as Chairman on April 15, 2025; director Jack Stover appointed Chairman.
- Dr. Dukes remains a board member after transitioning chairman role.
- Agreement replaces April 2024 offer letter; details in Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/0001104659-25-036366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/tm2512673d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-036366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer